Vancouver

As a global destination for health technology, Montreal’s life sciences ecosystem stands out as a world-class hub for biotechnology, pharmaceutical manufacturing and healthcare innovation.

The city is internationally recognized for its leadership in artificial intelligence (AI) for drug discovery, leveraging the world’s largest concentration of academic deep learning researchers to accelerate the R&D pipeline.

Montreal’s robust biopharma sector is anchored by a dense network of over 600 organizations, including global giants and agile biotech startups specializing in oncology, rare diseases and genomics.

The region is a powerhouse for clinical trials, supported by leading academic research centers like the McGill University Health Centre (RI-MUHC) and the Université de Montréal’s IRIC.

In the medical device sector, Montreal excels in digital health, surgical robotics and advanced diagnostics, driven by collaborative incubators like MEDTEQ+.

International investors are drawn to the city's highly skilled talent pool, which produces the highest number of life sciences graduates in Canada annually.

Strategic specialized clusters and CROs (contract research organizations) provide a seamless end-to-end environment for commercializing breakthrough therapies.

With a unique "gateway" position between North America and Europe, the city fosters a culture of cross-sector collaboration that transforms fundamental science into patient-ready solutions.

Today, Montreal continues to redefine the future of personalized medicine and sustainable health technologies on the global stage.